ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,97
0,35%
Dow Jones
39 864,63
-0,35%
DAX
18 768,96
0,33%
Brent Oil
83,50
-0,11%
Bitcoin
68 700,17
3,84%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Forma Therapeutics Holdings Inc (FMTX)

  7. Forma Therapeutics Holdings Inc (FMTX) Actualités

FMTX

Forma Therapeutics (FMTX)

Forma Therapeutics Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FMTX
DateHeureSourceTitreSymboleSociété
14/02/202314h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
24/10/202217h23Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202222h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202215h25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202215h19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202215h00Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202214h49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FMTXForma Therapeutics Holdings Inc
07/10/202214h17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
30/09/202215h00Business WireSickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the DiseaseNASDAQ:FMTXForma Therapeutics Holdings Inc
15/09/202223h26Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:FMTXForma Therapeutics Holdings Inc
15/09/202223h22Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:FMTXForma Therapeutics Holdings Inc
02/09/202222h31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202223h23Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202216h19Dow Jones NewsForma Therapeutics Shares Surge on Takeover by Novo NordiskNASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202214h52Dow Jones NewsNovo Nordisk to Buy Forma Therapeutics for $1.1 BillionNASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202214h00Business WireNovo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disordersNASDAQ:FMTXForma Therapeutics Holdings Inc
23/08/202212h15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Forma Therapeutics Holdings (FMTX)NASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202222h50Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202222h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202213h00Business WireForma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202205h21TipRanksForma Therapeutics Holdings (FMTX) Receives a Buy from SVB SecuritiesNASDAQ:FMTXForma Therapeutics Holdings Inc
02/08/202222h01PR Newswire (US)Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid LeukemiaNASDAQ:FMTXForma Therapeutics Holdings Inc
29/07/202213h05Business WireForma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022NASDAQ:FMTXForma Therapeutics Holdings Inc
12/07/202222h24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FMTXForma Therapeutics Holdings Inc
12/07/202213h05Business WireForma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:FMTXForma Therapeutics Holdings Inc
30/06/202213h05Business WireForma Therapeutics Announces Appointment of New Executive Team MembersNASDAQ:FMTXForma Therapeutics Holdings Inc
10/06/202213h22Business WireForma Therapeutics Announces Presentations at Upcoming Hematology ConferencesNASDAQ:FMTXForma Therapeutics Holdings Inc
09/06/202212h25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Forma Therapeutics Holdings (FMTX)NASDAQ:FMTXForma Therapeutics Holdings Inc
03/06/202222h13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FMTXForma Therapeutics Holdings Inc
03/06/202213h05Business WireForma Therapeutics to Present at the Jefferies Healthcare ConferenceNASDAQ:FMTXForma Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:FMTX

Dernières Valeurs Consultées

EU
FR1CIBFS7975
Credit Agricole CIB Fina...
TG
AT12
Aroundtown
BIT
P1ZU72
NLBNPIT1ZU72 20240920 32...
EU
ACAOR
Credit Agricole CIB Inte...
TG
A2RZ8E
Oma Savings Bank Oyj
DBI
3XJ5
INDBX RUS2000 DR 1C SK
NYSE
SRJ
Sears Accept Nts 7.0
TG
A1VQHR
Apple
USOTC
AERIF
Aquila European Renewabl... (PK)
NASDAQ
ANSCU
Agriculture and Natural ...
TG
A2R0BD
Aegon NV
USOTC
HRZSF
Global X S&P TSX 60 Inde... (CE)
TG
A2R9LF
Engie S.A
TG
A2R7Q1
Dassault Systemss
BIT
P1WEJ8
NLBNPIT1WEJ8 20240621 0.2
TG
A2R7JM
AT&T
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés